Barbara Fiorini Due
@Novo Holdings A S
Latest period2024 - Q3ReportedManaged Assets$2.013BTotal holdings37
Assets growth rate8.55%Assets growth rate (2-Q avg)18.26%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Novo Holdings A S's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 37 positions.
Assets under management
The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.013B in assets, with a quarterly growth rate of 8.55% and a 2-quarter average growth rate of 18.26%. The portfolio is managed by Barbara Fiorini Due, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
VTIVanguard Index Fds
| 14.61% | $294.076M 1.039M shares@ $283.16 avg price | |
TEMTempus Ai Inc
| 11.46% | $230.612M 4.074M shares@ $56.6 avg price | |
BNBrookfield Corp
| 9.22% | $185.559M 3.491M shares@ $53.16 avg price | Decreased -10.02% |
EWTXEdgewise Therapeutics Inc
| 7.36% | $148.127M 5.55M shares@ $26.69 avg price | Decreased -12.52% |
CORTCorcept Therapeutics Inc
| 5.55% | $111.598M 2.411M shares@ $46.28 avg price | |
ASMLAsml Holding N V
| 5.52% | $111.102M 133,336 shares@ $833.25 avg price | |
CRMSalesforce Inc
| 5.02% | $100.879M 368,560 shares@ $273.72 avg price | Decreased -23.24% |
PCVXVaxcyte Inc
| 4.26% | $85.703M 750,000 shares@ $114.27 avg price | Decreased -21.05% |
MIRMMirum Pharmaceuticals Inc
| 2.91% | $58.5M 1.5M shares@ $39.0 avg price | |
VRDNViridian Therapeutics Inc
| 2.7% | $54.259M 2.385M shares@ $22.75 avg price | Increased 19.25% |